1-(1-Benzylhexahydropyrrolo[3,4-b]pyrrol-5(1H)-yl)-2,2,2-trifluoroethanone
95%
- Product Code: 87233
CAS:
1279822-87-5
Molecular Weight: | 298.3 g./mol | Molecular Formula: | C₁₅H₁₇F₃N₂O |
---|---|---|---|
EC Number: | MDL Number: | MFCD28023895 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmacologically active molecules. Its structure, featuring a trifluoroethyl group and a benzyl-substituted pyrrolopyrrole moiety, makes it valuable for developing compounds with potential biological activity. Researchers often employ it in the design and optimization of drug candidates targeting central nervous system (CNS) disorders, such as anxiety, depression, or neurodegenerative diseases. The trifluoroethyl group can enhance metabolic stability and bioavailability, while the benzyl-pyrrolopyrrole scaffold may contribute to receptor binding affinity. Additionally, it has been explored in the development of enzyme inhibitors, particularly for targets involved in signal transduction pathways. Its versatility also extends to the creation of novel heterocyclic compounds for screening in drug discovery programs.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | ฿14,445.00 |
+
-
|
0.250 | 10-20 days | ฿26,622.00 |
+
-
|
1.000 | 10-20 days | ฿53,235.00 |
+
-
|
1-(1-Benzylhexahydropyrrolo[3,4-b]pyrrol-5(1H)-yl)-2,2,2-trifluoroethanone
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmacologically active molecules. Its structure, featuring a trifluoroethyl group and a benzyl-substituted pyrrolopyrrole moiety, makes it valuable for developing compounds with potential biological activity. Researchers often employ it in the design and optimization of drug candidates targeting central nervous system (CNS) disorders, such as anxiety, depression, or neurodegenerative diseases. The trifluoroethyl group can enhance metabolic stability and bioavailability, while the benzyl-pyrrolopyrrole scaffold may contribute to receptor binding affinity. Additionally, it has been explored in the development of enzyme inhibitors, particularly for targets involved in signal transduction pathways. Its versatility also extends to the creation of novel heterocyclic compounds for screening in drug discovery programs.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :